Abstract
The recent report from the American Academy of Pediatrics on the prevention of iron deficiency and iron deficiency anemia recommended increased iron intake for breast fed infants beginning at 4 months of age. This recommendation has not been without controversy. This paper will review the reasoning behind these new recommendations and include a physiologic review of iron metabolism as well as its physiologic importance including its role in neurodevelopment. It will review the diagnosis of both iron deficiency and iron deficiency anemia and how to prevent them in the breastfed infant. This includes introducing medicinal iron at 4 months of age and introducing foods that are rich in heme iron (red meat) when complementary feedings are introduced.
Keywords: Infants, breastfeeding, iron deficiency, iron deficiency anemia, neuroedevelopment
Current Pediatric Reviews
Title:The Iron Requirement of Breastfeeding Infants
Volume: 8 Issue: 4
Author(s): Frank R. Greer
Affiliation:
Keywords: Infants, breastfeeding, iron deficiency, iron deficiency anemia, neuroedevelopment
Abstract: The recent report from the American Academy of Pediatrics on the prevention of iron deficiency and iron deficiency anemia recommended increased iron intake for breast fed infants beginning at 4 months of age. This recommendation has not been without controversy. This paper will review the reasoning behind these new recommendations and include a physiologic review of iron metabolism as well as its physiologic importance including its role in neurodevelopment. It will review the diagnosis of both iron deficiency and iron deficiency anemia and how to prevent them in the breastfed infant. This includes introducing medicinal iron at 4 months of age and introducing foods that are rich in heme iron (red meat) when complementary feedings are introduced.
Export Options
About this article
Cite this article as:
R. Greer Frank, The Iron Requirement of Breastfeeding Infants, Current Pediatric Reviews 2012; 8(4) . https://dx.doi.org/10.2174/157339612803307741
DOI https://dx.doi.org/10.2174/157339612803307741 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
P-gp Inhibition-Based Strategies for Modulating Pharmacokinetics of Anticancer Drugs: An Update
Current Drug Metabolism Transbronchial Needle Aspiration (TBNA): Past Present and Future
Current Respiratory Medicine Reviews PPARγ in Angiogenesis and Vascular Development
Current Angiogenesis (Discontinued) Insight to Pharmacokinetics of TKIs: Optimizing Practical Guidelines for Individualized Therapy
Current Drug Metabolism Progress in the Discovery of Macrocyclic Histone Deacetylase Inhibitors for the Treatment of Cancer
Current Medicinal Chemistry Enhancement of Antitumor Effects of a New Boron Compound Combined with Ultrasound on the Mouse Ascites Tumor
Medicinal Chemistry Cancer Kinases and its Novel Inhibitors: Past, Present and Future Challenges
Current Drug Targets Inhibitors of DNA Methylation and Histone Deacetylation as Epigenetically Active Drugs for Anticancer Therapy
Current Pharmaceutical Design Liposomal Irinotecan in the Treatment of Refractory Pancreatic Cancer
Recent Patents on Anti-Cancer Drug Discovery Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
Current Gene Therapy Lenalidomide for Treatment of Myelodysplastic Syndromes
Current Pharmaceutical Design HLAs in Autoimmune Diseases: Dependable Diagnostic Biomarkers?
Current Rheumatology Reviews Theranostic Radiopharmaceuticals Targeting Cancer-Associated Fibroblasts
Current Radiopharmaceuticals Paris Saponin VII Induces Apoptosis and Cell Cycle Arrest in Erythroleukemia Cells by a Mitochondrial Membrane Signaling Pathway
Anti-Cancer Agents in Medicinal Chemistry Bortezomib: Proteasome Inhibition as a Novel Mechanism of Cancer Therapy-Implications for Hematological Malignancies
Letters in Drug Design & Discovery Protein Kinase B/AKT and Focal Adhesion Kinase: Two Close Signaling Partners in Cancer
Anti-Cancer Agents in Medicinal Chemistry Fungal Infection in Cystic Fibrosis
Current Respiratory Medicine Reviews The Role of 5-Hydroxymethylcytosine in Aging and Alzheimer’s Disease: Current Status and Prospects for Future Studies
Current Alzheimer Research Novel Insights into Targeting ATP-Binding Cassette Transporters for Antitumor Therapy
Current Medicinal Chemistry Lessons Learned from Two Decades of Clinical Trial Experience in Gene Therapy for Fanconi Anemia
Current Gene Therapy